336 related articles for article (PubMed ID: 29281608)
1. A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds.
Waksman R
Cleve Clin J Med; 2017 Dec; 84(12 Suppl 4):e20-e24. PubMed ID: 29281608
[TBL] [Abstract][Full Text] [Related]
2. Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.
Puricel S; Arroyo D; Corpataux N; Baeriswyl G; Lehmann S; Kallinikou Z; Muller O; Allard L; Stauffer JC; Togni M; Goy JJ; Cook S
J Am Coll Cardiol; 2015 Mar; 65(8):791-801. PubMed ID: 25720622
[TBL] [Abstract][Full Text] [Related]
3. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
[TBL] [Abstract][Full Text] [Related]
4. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.
Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL
Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting stents to prevent stent thrombosis and restenosis.
Im E; Hong MK
Expert Rev Cardiovasc Ther; 2016; 14(1):87-104. PubMed ID: 26567863
[TBL] [Abstract][Full Text] [Related]
6. From biodegradable polymers to bioresorbable vascular scaffolds: available evidence in the era of new-generation drug-eluting stents.
Magliulo F; Piccolo R; Franzone A; Esposito G; Danzi GB
Minerva Cardioangiol; 2018 Jun; 66(3):246-261. PubMed ID: 29160048
[TBL] [Abstract][Full Text] [Related]
7. Bioresorbable Stents in PCI.
Lindholm D; James S
Curr Cardiol Rep; 2016 Aug; 18(8):74. PubMed ID: 27312934
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of bioabsorbable versus durable polymer drug-eluting stents in 20,005 patients with coronary artery disease: an update.
Lupi A; Gabrio Secco G; Rognoni A; Lazzero M; Fattori R; Sheiban I; Sante Bongo A; Bolognese L; Agostoni P; Porto I
Catheter Cardiovasc Interv; 2014 May; 83(6):E193-206. PubMed ID: 24478247
[TBL] [Abstract][Full Text] [Related]
9. Long-term comparative analysis from an all-comer cohort of coronary patients treated using first- and second-generation drug-eluting stents.
Codner P; Bental T; Assali A; Vaknin-Assa H; Lev E; Kornowski R
J Invasive Cardiol; 2014 Aug; 26(8):378-84. PubMed ID: 25091097
[TBL] [Abstract][Full Text] [Related]
10. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
[TBL] [Abstract][Full Text] [Related]
11. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
[TBL] [Abstract][Full Text] [Related]
12. From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.
Tenekecioglu E; Bourantas C; Abdelghani M; Zeng Y; Silva RC; Tateishi H; Sotomi Y; Onuma Y; Yılmaz M; Serruys PW
Expert Rev Med Devices; 2016; 13(3):271-86. PubMed ID: 26782080
[TBL] [Abstract][Full Text] [Related]
13. Impact of the stent length on long-term clinical outcomes following newer-generation drug-eluting stent implantation.
Choi IJ; Koh YS; Lim S; Kim JJ; Chang M; Kang M; Hwang BH; Kim CJ; Kim TH; Seo SM; Shin DI; Park MW; Choi YS; Park HJ; Her SH; Kim DB; Kim PJ; Lee JM; Park CS; Moon KW; Chang K; Kim HY; Yoo KD; Jeon DS; Chung WS; Seung KB
Am J Cardiol; 2014 Feb; 113(3):457-64. PubMed ID: 24332246
[TBL] [Abstract][Full Text] [Related]
14. Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014.
Byrne RA; Joner M; Kastrati A
Eur Heart J; 2015 Dec; 36(47):3320-31. PubMed ID: 26417060
[TBL] [Abstract][Full Text] [Related]
15. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
[TBL] [Abstract][Full Text] [Related]
16. Very early neointimal coverage of new biodegradable polymer drug-eluting stent compared with durable polymer everolimus-eluting stent evaluated by optical frequency domain imaging.
Kobayashi N; Ito Y; Yamawaki M; Araki M; Sakai T; Sakamoto Y; Mori S; Tsutsumi M; Nauchi M; Honda Y; Tokuda T; Makino K; Shirai S; Hirano K
Int J Cardiovasc Imaging; 2018 Apr; 34(4):515-522. PubMed ID: 29159531
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials.
Stefanini GG; Baber U; Windecker S; Morice MC; Sartori S; Leon MB; Stone GW; Serruys PW; Wijns W; Weisz G; Camenzind E; Steg PG; Smits PC; Kandzari D; Von Birgelen C; Galatius S; Jeger RV; Kimura T; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Valgimigli M; Kastrati A; Chieffo A; Mehran R
Lancet; 2013 Dec; 382(9908):1879-88. PubMed ID: 24007976
[TBL] [Abstract][Full Text] [Related]
18. Fully bioresorbable drug-eluting coronary scaffolds: A review.
Charpentier E; Barna A; Guillevin L; Juliard JM
Arch Cardiovasc Dis; 2015; 108(6-7):385-97. PubMed ID: 26113479
[TBL] [Abstract][Full Text] [Related]
19. Stent thrombosis with drug-eluting stents: is the paradigm shifting?
Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Genereux P; Branzi A; Stone GW
J Am Coll Cardiol; 2013 Nov; 62(21):1915-1921. PubMed ID: 24036025
[TBL] [Abstract][Full Text] [Related]
20. Bioresorbable vascular scaffolds for the treatment of coronary artery disease: Clinical outcomes from randomized controlled trials.
Rizik DG; Hermiller JB; Kereiakes DJ
Catheter Cardiovasc Interv; 2016 Nov; 88(S1):21-30. PubMed ID: 27797464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
